(1,3)-Beta-D-Glucan test in Dubai and across the UAE to detect early signs of fungal infections like Aspergillus. This sensitive blood test helps identify invasive fungal infections in high-risk patients — including those with weakened immunity, post-transplant, or on chemotherapy. Results available within 15 days.

Overview

The (1,3)-Beta-D-Glucan test is a serum-based biomarker assay that detects a key component of fungal cell walls. It is highly useful in the early identification of invasive fungal infections, including Aspergillus, Candida, and Pneumocystis jirovecii. This test does not identify the specific fungus but signals the presence of a fungal infection, enabling earlier treatment. Results are typically available within 15 days.

Why You Need This Test

• Early detection of invasive fungal infections in immunocompromised individuals (e.g., cancer, transplant, or ICU patients).
• Monitor patients on long-term steroids or immunosuppressive therapy.
• Support diagnosis when symptoms include fever, cough, chest pain, or shortness of breath unresponsive to antibiotics.
• Complement imaging (e.g., CT scan) and other tests like galactomannan or fungal culture.
• Reduce delays in starting antifungal therapy — critical for survival in high-risk groups.
• Non-invasive alternative to lung biopsy for suspected Aspergillus.
• Available with home sample collection across Dubai, Abu Dhabi, Sharjah, and all Emirates.

Symptoms & Risk Factors

Common Symptoms

• Persistent fever not responding to antibiotics.
• Dry cough or chest pain — may mimic pneumonia.
• Shortness of breath or hypoxia.
• Fatigue and night sweats.
• Hemoptysis (coughing up blood) in advanced cases.

Risk Factors

• Weakened immune system: HIV/AIDS, chemotherapy, organ/bone marrow transplant.
• Long-term corticosteroid use or immunosuppressants.
• Lung diseases: COPD, cystic fibrosis, prior TB.
• ICU admission with mechanical ventilation.
• Neutropenia (low white blood cells).
• Exposure to construction/dust (source of Aspergillus spores).

How the Test Works

The test detects (1,3)-beta-D-glucan, a polysaccharide found in the cell walls of many pathogenic fungi (except Cryptococcus and mucormycetes). A positive result suggests fungal invasion, even before cultures turn positive.

• Step 1 — Appointment: visit a certified lab or book home blood collection (available in Dubai, Abu Dhabi, Sharjah, and other Emirates).
• Step 2 — Blood draw: a trained technician collects a serum sample (plain tube) via venipuncture (takes under 5 minutes).
• Step 3 — Lab analysis: performed using sensitive immunoassay to detect glucan levels.
• Step 4 — Results: delivered securely within 15 business days.

This test supports early clinical decisions — especially when imaging or cultures are inconclusive.

Specimen (Sample Type)

• Required sample: Serum, Plain tube
• Volume: 1 mL
• Collection method: standard venipuncture
• Transport: 2–8°C (refrigerated), protect from light
• Avoid: IV immunoglobulins, albumin, or hemodialysis within 24 hours (can cause false positives)

Risks & Safety

• Mild pain or bruising at the needle site (temporary).
• Dizziness (rare, especially in frail patients).
• Very low infection risk with sterile technique.
• No special risks from the test itself — it’s a standard blood draw.

Result Interpretation

Normal Range

• < 60 pg/mL: Negative — no significant fungal antigen detected.

Positive Result (> 60 pg/mL)

• Suggests invasive fungal infection (e.g., Aspergillus, Candida, Pneumocystis).
• Does not identify the specific fungus — clinical correlation needed.
• May require follow-up with galactomannan test, CT scan, or bronchoalveolar lavage.

Indeterminate (40–60 pg/mL)

• Borderline result — repeat testing or clinical monitoring advised.

Consequences if Untreated

• Progression to severe infection: invasive aspergillosis can spread to brain, kidneys, or heart.
• Lung damage: cavities, hemorrhage, or respiratory failure.
• High mortality: up to 50–90% in immunocompromised patients if diagnosis is delayed.
• Increased ICU stay and treatment complexity.

Factors Affecting Test Results

• False positives: due to IV immunoglobulins, albumin, dialysis filters, gauze, or bacteremia (Streptococcus pneumoniae).
• False negatives: early infection, localized disease, or use of antifungal medications.
• Recent surgery or IV fluids containing glucan contaminants.
• Type of fungus: Cryptococcus and mucormycetes do not produce beta-D-glucan.

FAQs

Limitations

• Not specific to Aspergillus — detects multiple fungi.
• Cannot replace culture or imaging — must be interpreted with clinical findings.
• May yield false positives due to certain IV products or bacterial infections.
• Not useful for Mucor, Rhizopus, or Cryptococcus.

Book Your (1,3)-Beta-D-Glucan (Aspergillus) Test Today

Don’t wait — early detection saves lives in fungal infections.

• Home Sample Collection Available (Across Abu Dhabi, Dubai, Sharjah, Ajman, RAK, Umm Al Quwain, Fujairah)
• Fast, Accurate, Confidential Results in 15 Days
• Price: AED 250
• ✅ Certified Labs
• 👩‍⚕️ Licensed Technicians
• 🔒 Secure Reporting

ABPA MINI Panel (Allergic Bronchopulmonary Aspergillosis) Test in Dubai and across the UAE to detect fungal hypersensitivity in asthma and cystic fibrosis patients. This specialized blood test helps diagnose ABPA — a serious allergic reaction to the Aspergillus fumigatus mold that can cause progressive lung damage if untreated. Combines key biomarkers for accurate detection. Results available within 5–7 days.

Overview

The ABPA MINI Panel is a targeted blood test used to diagnose Allergic Bronchopulmonary Aspergillosis (ABPA), a condition where the immune system overreacts to Aspergillus fumigatus, a common fungus found in dust and decaying organic matter. It primarily affects individuals with asthma or cystic fibrosis, leading to worsening respiratory symptoms and potential lung damage. The panel measures total IgE, Aspergillus-specific IgE, and Aspergillus precipitins (IgG) — key markers for confirming ABPA. Results are typically available within 5–7 business days.

Why You Need This Test

• Diagnose ABPA in patients with uncontrolled asthma or cystic fibrosis.
• Evaluate worsening cough, wheezing, or recurrent chest infections.
• Detect fungal sensitization before permanent lung damage occurs.
• Monitor disease progression or response to steroid/antifungal therapy.
• Rule out fungal bronchitis or aspergilloma in lung imaging abnormalities.
• Support early intervention to prevent bronchiectasis or pulmonary fibrosis.
• Available with home blood collection service across Dubai, Abu Dhabi, Sharjah, and all Emirates.

Symptoms & Risk Factors

Common Symptoms

• Worsening asthma not responding to standard inhalers
• Chronic cough with brownish mucus plugs
• Wheezing and shortness of breath
• Fever or malaise without active infection
• Chest tightness or recurrent pneumonia-like episodes

Risk Factors

• Long-standing asthma, especially moderate to severe
• Cystic fibrosis (CF) — up to 15% develop ABPA
• High exposure to mold (e.g., farming, composting, damp environments)
• Elevated IgE levels on prior testing
• History of pulmonary infiltrates on chest X-ray or CT scan
• Smoking or lung structural damage

How the Test Works

The ABPA MINI Panel evaluates three critical immune markers to confirm fungal hypersensitivity:

• Total IgE: usually markedly elevated (>1000 IU/mL) in active ABPA.
• Aspergillus-specific IgE: detects allergic sensitization to Aspergillus fumigatus.
• Aspergillus precipitins (IgG): indicates chronic exposure and immune complex formation.

Used together, these markers help differentiate ABPA from simple fungal allergy or infection. The test is performed on a blood sample collected at home or in lab. Results are analyzed in certified pathology labs and delivered securely within 5–7 business days.

Sample Type

• We take: Venous blood sample (serum)
• Volume: 5–7 mL (1 red-top or serum separator tube)
• Collection method: standard venipuncture (arm draw)
• Home service available: trained phlebotomist collects sample at your residence
• Storage: sample kept at room temperature or refrigerated before lab processing
• Note: hemolyzed or severely lipemic samples may require recollection

Risks & Safety

• Minimal risk — standard blood draw with brief discomfort.
• No fasting or downtime required.
• Safe for adults and children with asthma or cystic fibrosis.
• Very low risk of bruising or infection at the puncture site.

Result Interpretation

Normal Range

• Total IgE: < 100 IU/mL (varies by age and lab)
• Aspergillus IgE: < 0.35 kU/L (negative)
• Aspergillus IgG (Precipitins): Not detected

Positive/Abnormal Results

• Suggestive of ABPA if:
  • Total IgE > 1000 IU/mL
  • Elevated Aspergillus-specific IgE
  • Presence of Aspergillus IgG precipitins
  • Clinical symptoms and imaging support diagnosis

Borderline or Inconclusive

• May require repeat testing, chest imaging (CT), or sputum culture.
• Follow-up with a pulmonologist or allergist is recommended.

Consequences if Untreated

• Progressive lung damage including bronchiectasis and fibrosis.
• Irreversible decline in lung function.
• Increased hospitalizations due to asthma exacerbations.
• Development of fungal balls (aspergillomas) in lung cavities.
• Reduced quality of life and exercise tolerance.

Factors Affecting Test Results

• Recent steroid use: may lower IgE levels and mask diagnosis.
• Antifungal medications: reduce fungal load and antibody levels.
• Other fungal allergies: possible cross-reactivity with other molds.
• Atopic conditions: high total IgE in eczema or allergic rhinitis.
• Timing: testing too early in disease course may yield false negatives.
• Lab variability: reference ranges may differ between testing platforms.

FAQs

Limitations

• Not a standalone diagnostic — must be combined with clinical symptoms, imaging, and pulmonary function tests.
• Steroid use can suppress IgE, leading to false-negative results.
• Does not detect active fungal infection — only allergic/immune response.
• May miss early-stage ABPA if markers are not yet elevated.
• Requires expert interpretation by a pulmonologist or immunologist.

Book Your ABPA MINI Panel Test Today

Don’t ignore worsening asthma or chronic cough — rule out fungal allergy early.

• Home Blood Collection Available (Across Dubai, Abu Dhabi, Sharjah & All Emirates)
• Comprehensive 3-Marker Panel for Accurate ABPA Screening
• Results in 5–7 Days
• Price: AED 475
• ✅ CLIA-Certified Labs | Allergy & Immunology Validated
• 🩸 Professional Phlebotomist at Home
• 🔒 Secure Digital Reporting

ABPA Screen (Total IgE & Specific IgE Af) test available in Dubai and across the UAE to detect allergic bronchopulmonary aspergillosis (ABPA), a hypersensitivity reaction to the fungus Aspergillus fumigatus. This comprehensive screening measures both total IgE levels and specific IgE antibodies against Aspergillus fumigatus, aiding early diagnosis in patients with asthma or cystic fibrosis. Results available within 5–7 days.

Overview

The ABPA Screen is a blood test that evaluates the immune response to Aspergillus fumigatus, a common mold found in the environment. It includes measurement of total immunoglobulin E (IgE) and specific IgE antibodies directed against Aspergillus fumigatus (Af). Elevated levels suggest an allergic reaction in the lungs, commonly seen in allergic bronchopulmonary aspergillosis (ABPA), a condition that can mimic or worsen asthma and cystic fibrosis. This test is crucial for early detection and preventing lung damage. Results are typically available within 5–7 business days.

Why You Need This Test

• Diagnose allergic bronchopulmonary aspergillosis (ABPA) in patients with poorly controlled asthma or cystic fibrosis.
• Evaluate chronic cough, wheezing, or recurrent chest infections unresponsive to standard treatment.
• Investigate elevated total IgE levels without clear allergic cause.
• Monitor disease progression or treatment response in known ABPA cases.
• Assess patients with central bronchiectasis on imaging.
• Support diagnosis when sputum culture shows Aspergillus but infection is not confirmed.
• Available with home blood collection in Dubai, Abu Dhabi, Sharjah, and all Emirates.

Symptoms & Risk Factors

Common Symptoms

• Wheezing or worsening asthma not responding to inhalers
• Chronic cough with brownish mucus plugs
• Fever or malaise without infection
• Shortness of breath during routine activities
• Chest tightness or recurrent pneumonia-like episodes

Risk Factors

• Asthma, especially severe or corticosteroid-dependent
• Cystic fibrosis (CF) – up to 15% may develop ABPA
• Long-term exposure to mold (e.g., compost, decaying vegetation)
• Elevated total IgE (>1000 IU/mL)
• History of pulmonary infiltrates or bronchiectasis
• Positive skin test to Aspergillus

How the Test Works

The ABPA Screen evaluates two key immune markers:

• Total IgE: Often markedly elevated in ABPA (typically >1000 IU/mL).
• Specific IgE to Aspergillus fumigatus: Indicates sensitization to the fungus.

Together, these help differentiate ABPA from simple fungal colonization or other allergic conditions. The test uses a blood sample analyzed via immunoassay (e.g., ImmunoCAP or ELISA) for high sensitivity and specificity.

• Step 1 — Appointment: Schedule a blood draw at a lab or request home collection.
• Step 2 — Sample: A standard venous blood sample (serum) is collected.
• Step 3 — Analysis: Lab tests for total IgE and specific IgE Af levels.
• Step 4 — Results: Delivered securely within 5–7 business days.

This test is a cornerstone in diagnosing ABPA and guiding steroid or antifungal therapy.

Sample Type

• We take: Venous blood (serum sample)
• Volume: 1–2 mL of blood in a serum separator tube (SST)
• Container: Gold-top or red-top tube (clotting required)
• How it’s collected: Standard venipuncture (arm draw)
• Storage: Serum must be separated within 2 hours and stored at 2–8°C
• Note: Hemolyzed or lipemic samples may affect accuracy

Risks & Safety

• Minimal risk — standard blood draw with brief discomfort.
• No fasting or special prep required for this test.
• No side effects expected post-collection.
• Safe for adults, adolescents, and children.
• Home collection available with trained phlebotomists.

Result Interpretation

Normal Range

• Total IgE: < 100 IU/mL (varies by age and lab)
• Specific IgE Af: < 0.35 kU/L (negative)
• Levels are age-dependent; higher in children and allergic individuals

Elevated Levels

• Total IgE > 1000 IU/mL + positive Specific IgE Af strongly suggests ABPA.
• May also indicate:
  • Aspergillus sensitization without full ABPA
  • Severe atopic asthma
  • Parasitic infections (can elevate total IgE)

Low/Normal Levels

• Make ABPA less likely, but do not fully rule it out.
• May suggest:
  • Non-allergic asthma
  • Bacterial or viral bronchitis
  • Other lung conditions (e.g., COPD, TB)

Consequences if Untreated

• Progressive lung damage and bronchiectasis.
• Permanent decline in lung function and breathing capacity.
• Chronic steroid dependence due to worsening asthma.
• Pulmonary fibrosis in advanced cases.
• Increased risk of respiratory failure over time.

Factors Affecting Test Results

• Recent corticosteroid use: may suppress IgE levels.
• Antihistamines: do not affect IgE levels but may interfere with skin testing.
• Other fungal allergies: may cause cross-reactivity.
• Parasitic infections: can elevate total IgE independently.
• Age: children naturally have higher IgE levels.
• Smoking: may influence immune markers.

FAQs

Limitations

• Not diagnostic alone — must be combined with clinical and radiological findings.
• Steroid use can suppress IgE, leading to false-negative results.
• False positives possible in other fungal allergies or parasitic infections.
• Requires careful interpretation by a pulmonologist or allergist.
• Normal IgE does not completely rule out ABPA in early stages.

Book Your ABPA Screen Test Today

Don’t ignore persistent asthma-like symptoms — rule out fungal allergy with a simple blood test.

• Home Blood Collection Available (Dubai, Abu Dhabi, Sharjah & all Emirates)
• Accurate & Reliable Testing in Certified Labs
• Price: AED 400
• ✅ Immunoassay Technology | Allergology-Grade Analysis
• 💉 Trained Phlebotomists | Comfortable at-Home Service
• 🔒 Confidential Results in 5–7 Days

Acetylcholinesterase (OPC Poisoning) Plasma Test in Dubai and across the UAE to detect and monitor organophosphate or carbamate pesticide exposure. This critical test measures enzyme activity in the blood, helping confirm organophosphate compound (OPC) poisoning — a life-threatening condition often caused by insecticide exposure. Results available within 7–10 days.

Overview

The Acetylcholinesterase Plasma Test measures the activity of acetylcholinesterase — an enzyme essential for normal nerve function — in the bloodstream. Organophosphate (OP) and carbamate pesticides inhibit this enzyme, leading to toxic accumulation of acetylcholine and severe neurological symptoms. This test is vital for confirming exposure, assessing severity, and guiding treatment in suspected poisoning cases. It is especially important for agricultural workers, emergency cases, and patients with unexplained neurological symptoms. Results are typically available within 7–10 business days.

Why You Need This Test

• Confirm organophosphate or carbamate pesticide poisoning in acute or chronic exposure.
• Evaluate patients with unexplained neurological symptoms after chemical exposure.
• Assess severity of poisoning and guide antidote therapy (e.g., atropine, pralidoxime).
• Monitor recovery and enzyme regeneration during treatment.
• Screen agricultural, pest control, or industrial workers with potential exposure.
• Support diagnosis in cases of intentional ingestion or suicide attempts.
• Available with rapid blood draw services across Dubai, Abu Dhabi, Sharjah, and all Emirates.

Symptoms & Risk Factors

Common Symptoms (Acute Poisoning)

• Muscle twitching, weakness, or paralysis
• Excessive salivation, sweating, or tearing
• Nausea, vomiting, or diarrhea
• Breathing difficulties or bronchospasm
• Blurred vision or pinpoint pupils (miosis)
• Anxiety, confusion, or seizures
• Low heart rate (bradycardia)

Risk Factors

• Occupational exposure to pesticides (farmers, sprayers, gardeners)
• Living in agricultural areas with frequent pesticide use
• Poor use of protective equipment during chemical handling
• Ingestion of contaminated food or water
• Intentional self-harm using insecticides
• Chronic low-level exposure leading to subtle neurological effects

How the Test Works

Organophosphates and carbamates block acetylcholinesterase, the enzyme that breaks down acetylcholine in nerve endings. When inhibited, acetylcholine builds up, causing continuous nerve signaling and toxic effects. The plasma acetylcholinesterase test measures enzyme activity in blood — lower levels indicate greater exposure and poisoning severity.

• Step 1 — Blood draw: a healthcare professional collects a blood sample from your arm.
• Step 2 — Sample handling: plasma is separated and preserved for specialized testing.
• Step 3 — Laboratory analysis: enzyme activity is measured using spectrophotometric methods.
• Step 4 — Interpretation: results compared to normal reference ranges.
• Step 5 — Results: securely delivered within 7–10 business days.

This test is crucial for diagnosing and managing a potentially fatal condition.

Sample Type

• We take: Blood sample (plasma)
• Volume: 3–5 mL collected in a green-top (heparin) or specific enzyme tube
• Collection: venous blood draw from the arm
• Handling: must be processed within 4–6 hours; plasma separated and frozen
• Storage: stored at -20°C or lower until analysis
• Note: delayed processing or hemolyzed samples may affect accuracy

Risks & Safety

• Minimal risk — standard blood draw with slight pain or bruising at the site.
• No fasting or special prep required unless directed.
• Safe for adults and children when medically necessary.
• Critical in emergencies — helps guide life-saving treatment.

Result Interpretation

Normal Range

• Normal: Varies by lab — typically 5,000–12,000 U/L (method-dependent)
• Baseline levels differ between individuals; serial testing is more informative

Reduced Activity

• 50–70% of normal: Mild inhibition — possible early or chronic exposure
• 30–50% of normal: Moderate poisoning — clinical symptoms likely
• Below 30%: Severe inhibition — high risk of respiratory failure
• Strongly suggests:
  • Organophosphate poisoning
  • Carbamate exposure
  • Chronic pesticide contact

Important Notes

• Plasma cholinesterase (pseudo-cholinesterase) declines faster than red blood cell enzyme.
• Levels may regenerate in days to weeks after exposure ends.
• Results should be correlated with clinical symptoms and exposure history.

Consequences if Untreated

• Respiratory failure due to paralysis of breathing muscles.
• Seizures or coma from uncontrolled nerve activity.
• Prolonged ICU stay and mechanical ventilation.
• Intermediate syndrome (muscle weakness 24–96 hrs post-exposure).
• Long-term neurological damage or cognitive deficits.
• Death if not diagnosed and treated promptly.

Factors Affecting Test Results

• Time since exposure: enzyme levels drop rapidly after poisoning.
• Treatment with oximes: may partially restore enzyme activity.
• Genetic variations: some people naturally have lower baseline levels.
• Liver disease: reduces enzyme production.
• Pregnancy: may lower plasma cholinesterase.
• Sample delay: improper handling can degrade enzyme activity.
• Other toxins: certain drugs or chemicals may interfere.

FAQs

Limitations

• Results take 7–10 days — not suitable for real-time emergency diagnosis (clinical assessment is primary).
• Must be interpreted with exposure history and symptoms.
• Plasma enzyme regenerates faster than RBC enzyme — may not reflect long-term exposure.
• Not all labs offer this test — requires specialized equipment and expertise.
• Baseline levels vary — serial testing is more valuable than a single result.

Book Your Acetylcholinesterase (OPC Poisoning) Plasma Test Today

If you or someone has been exposed to pesticides, get tested to confirm poisoning and support proper treatment.

• Fast Blood Collection in Dubai, Abu Dhabi, Sharjah & All Emirates
• Accurate, Lab-Certified Results in 7–10 Days
• Price: AED 300
• ✅ Accredited Labs | Toxicology-Grade Testing
• 💉 Professional Phlebotomy at Home or Clinic
• 🔒 Confidential & Secure Reporting

Acid Fast Bacilli (AFB) Culture (Blood & Bone Marrow) test in Dubai and across the UAE to detect mycobacterial infections, including tuberculosis (TB) and disseminated (systemic) mycobacteriosis. This specialized culture test is essential when TB is suspected beyond the lungs — such as in bone marrow, bloodstream, or immune-compromised patients. Results available within 4–6 weeks.

Overview

The Acid Fast Bacilli (AFB) Culture from blood or bone marrow is a definitive diagnostic test to identify the presence of slow-growing mycobacteria, primarily Mycobacterium tuberculosis and non-tuberculous mycobacteria (NTM). Unlike rapid tests, culture remains the gold standard for confirming active infection, enabling species identification and antibiotic susceptibility testing. Due to the slow growth of these organisms, results typically take 4–6 weeks. This test is crucial for diagnosing extrapulmonary and disseminated TB, especially in immunocompromised individuals.

Why You Need This Test

• Diagnose disseminated tuberculosis (miliary TB) — when TB spreads through the bloodstream.
• Evaluate unexplained fever of unknown origin (FUO) lasting weeks.
• Confirm infection in patients with HIV/AIDS, organ transplant, or on immunosuppressive therapy.
• Investigate anemia, low platelets, or abnormal bone marrow findings.
• Detect mycobacteremia (bacteria in the blood) in critically ill patients.
• Guide targeted antibiotic treatment based on culture and sensitivity results.
• Available at specialized labs in Dubai, Abu Dhabi, Sharjah, and across the UAE with expert microbiology support.

Symptoms & Risk Factors

Common Symptoms

• Prolonged fever (lasting >2–3 weeks) without clear cause
• Night sweats, chills, and fatigue
• Unintentional weight loss and loss of appetite
• Pallor, weakness, or bleeding (due to bone marrow involvement)
• Enlarged lymph nodes, liver, or spleen
• Joint pain or back pain (if spine is involved)

Risk Factors

• HIV infection or advanced immune suppression
• History of pulmonary or extrapulmonary TB
• Close contact with someone who has active TB
• Living in or traveling to high-TB-burden countries
• Organ transplant recipients or those on chemotherapy/biologics
• Chronic kidney disease or diabetes
• Recent bone marrow biopsy with suspicious findings

How the Test Works

AFB culture detects live mycobacteria in blood or bone marrow samples. These bacteria grow extremely slowly and require special nutrient media and prolonged incubation.

• Step 1 — Sample collection: blood drawn via venipuncture or bone marrow aspirate collected by a hematologist or specialist.
• Step 2 — Inoculation: sample is placed into liquid and solid culture media that support mycobacterial growth.
• Step 3 — Incubation: cultures are monitored for up to 6 weeks using automated systems (e.g., MGIT).
• Step 4 — Identification: any growth is confirmed as M. tuberculosis or NTM using molecular tests (e.g., PCR).
• Step 5 — Sensitivity testing: determines which antibiotics will effectively treat the infection.
• Step 6 — Results: final report delivered within 4–6 weeks.

This test is vital for confirming systemic TB and ensuring accurate, life-saving treatment.

Sample Type

• We take:
  • Blood: 5–10 mL collected in AFB culture bottles (sterile conditions)
  • Bone Marrow: aspirate collected under local anesthesia by a specialist
• Volume: depends on patient age and clinical indication
• Collection method: sterile technique to prevent contamination
• Transport: immediate delivery to the lab under controlled conditions
• Note: bone marrow procedure is performed at hospitals or clinics; blood draw available at collection centers

Risks & Safety

• Blood draw: minimal risk — slight pain, bruising, or infection at the site.
• Bone marrow aspiration: performed under local anesthesia; may cause brief pain, pressure, or soreness.
• No risk of spreading TB to others during sample collection when proper precautions are followed.
• Safe for adults and older children under medical supervision.

Result Interpretation

Normal Range

• Negative: No growth of acid-fast bacilli after 6 weeks
• Indicates absence of systemic mycobacterial infection (but does not rule out localized TB)

Positive Result

• Indicates:
  • Mycobacterium tuberculosis complex — confirms active TB infection
  • Non-tuberculous mycobacteria (NTM) — may be pathogenic or contaminant
• Further testing (e.g., PCR, sensitivity) will identify the exact species and guide treatment.

Contamination or Indeterminate

• Rarely, skin flora may contaminate the sample — lab will report accordingly.
• If clinical suspicion remains high, repeat testing or alternative diagnostics may be needed.

Consequences if Untreated

• Progressive, life-threatening infection affecting multiple organs.
• Severe anemia, bleeding, or bone marrow failure due to marrow involvement.
• Spread to brain (TB meningitis), spine, or liver.
• Multi-organ failure in immunocompromised patients.
• Drug-resistant TB if incorrect or delayed treatment is started.

Factors Affecting Test Results

• Antibiotic use: prior TB drugs may suppress growth and cause false-negative results.
• Small sample volume: reduces detection sensitivity.
• Improper handling or delay in transport: can kill bacteria before culture.
• Low bacterial load: common in early or mild disease.
• Immune status: HIV+ patients may have higher yield in blood cultures.
• Lab expertise: requires specialized biosafety level 3 (BSL-3) facilities.

FAQs

Limitations

• Long turnaround time: 4–6 weeks due to slow growth of mycobacteria.
• Low sensitivity: may miss infection if bacterial load is very low.
• Requires specialized labs with biosafety and culture expertise.
• Bone marrow aspiration is an invasive procedure requiring trained personnel.
• Cannot distinguish live vs. dead bacteria without culture growth.
• Should be interpreted alongside clinical findings, imaging, and other TB tests (e.g., GeneXpert, interferon-gamma release assays).

Book Your AFB Culture (Blood & Bone Marrow) Test Today

Suspect systemic TB or unexplained prolonged illness? Get a definitive diagnosis with trusted, lab-confirmed testing across the UAE.

• Available for Blood & Bone Marrow Samples (Referral for marrow procedure required)
• Accurate, Lab-Confirmed Results in 4–6 Weeks
• Price: AED 350 (Lab Processing Fee)
• ✅ CLIA-Grade Labs | TB-Specialized Microbiology
• 🏥 Partner Hospitals for Bone Marrow Collection
• 🔒 Confidential & Secure Reporting

Acid Fast Bacilli (AFB) Culture (Extra Pulmonary): MGIT Test in Dubai and across the UAE to detect tuberculosis (TB) outside the lungs. This advanced diagnostic test identifies *Mycobacterium tuberculosis* in non-respiratory samples such as lymph nodes, urine, cerebrospinal fluid (CSF), joint fluid, or tissue biopsies. Using the automated MGIT (Mycobacteria Growth Indicator Tube) system, it offers high sensitivity and faster detection than traditional methods. Results available within 4–6 weeks.

Overview

The AFB Culture (Extra Pulmonary): MGIT Test is a highly sensitive microbiological test used to confirm the presence of *Mycobacterium tuberculosis* in body fluids or tissues other than sputum. Unlike smear microscopy, which only detects visible bacilli, culture allows for definitive identification and viability testing. The **MGIT system** uses fluorescent technology to detect growth early, improving diagnostic accuracy. This test is essential for diagnosing **extrapulmonary TB**, a challenging form of infection that can affect the lymph nodes, brain, kidneys, bones, and abdomen. Results are typically available within 4–6 weeks due to the slow-growing nature of mycobacteria.

Why You Need This Test

• Confirm diagnosis of extrapulmonary tuberculosis (TB) when symptoms suggest infection outside the lungs.
• Evaluate patients with enlarged lymph nodes, meningitis, or unexplained fever.
• Test body fluids such as CSF, pleural fluid, ascites, synovial fluid, or urine.
• Analyze tissue biopsies from lymph nodes, bone, or abdominal organs.
• Follow-up after positive AFB smear or GeneXpert result from non-respiratory samples.
• Differentiate between TB and other chronic infections or cancers.
• Available at accredited laboratories across Dubai, Abu Dhabi, Sharjah, and all Emirates.

Symptoms & Risk Factors

Common Symptoms

• Persistent fever or night sweats without clear cause
• Unexplained weight loss and fatigue
• Swollen lymph nodes (especially in neck or groin)
• Headaches, confusion, or seizures (if TB affects the brain — tuberculous meningitis)
• Painful or swollen joints (TB arthritis)
• Abdominal pain, swelling, or ascites (peritoneal TB)
• Blood in urine or frequent urination (renal TB)

Risk Factors

• Known exposure to active TB (household or close contact)
• History of latent or pulmonary TB
• Low immunity due to HIV/AIDS, diabetes, or steroid use
• Organ transplant recipients on immunosuppressive drugs
• Healthcare workers exposed to TB patients
• Living in or traveling to high-TB-burden countries
• Malnutrition or chronic illness

How the Test Works

The MGIT (Mycobacteria Growth Indicator Tube) system is an automated liquid culture method that detects the growth of acid-fast bacilli, including *M. tuberculosis*, in non-pulmonary specimens. It is more sensitive than solid culture and provides results faster.

• Step 1 — Sample collection: a clinical sample (e.g., lymph node aspirate, CSF, urine, tissue) is collected by a healthcare provider using sterile technique.
• Step 2 — Transport: the sample is placed in a sterile container and sent to a certified lab under controlled conditions.
• Step 3 — Inoculation: the sample is processed and inoculated into MGIT tubes containing growth medium and a fluorescent sensor.
• Step 4 — Incubation: tubes are incubated in an automated system that monitors for fluorescence indicating bacterial growth.
• Step 5 — Identification: positive cultures are further tested with molecular methods (e.g., PCR) to confirm *M. tuberculosis*.
• Step 6 — Results: final report available within 4–6 weeks.

This test is critical for diagnosing hidden forms of TB that are easily missed without proper culture.

Sample Type

• We test: Non-respiratory clinical specimens such as:
  • Cerebrospinal fluid (CSF)
  • Lymph node aspirate or biopsy
  • Urine
  • Pleural, peritoneal, or synovial fluid
  • Tissue samples (e.g., liver, bone marrow)
• Volume: varies by sample type (e.g., 5–10 mL CSF, 20–50 mL urine, full aspirate volume)
• Container: sterile, leak-proof container (provided by the lab or clinic)
• Collection method: performed by trained medical personnel
• Storage: refrigerate (2–8°C) if delay in transport; do not freeze
• Note: improper handling or contamination may lead to false results or culture failure

Risks & Safety

• Minimal risk — associated with sample collection (e.g., lumbar puncture, biopsy), not the test itself.
• No radiation or infection risk from the culture process.
• Performed in BSL-3 laboratories to ensure safety and prevent contamination.
• All samples handled under strict biosafety protocols.

Result Interpretation

Normal Range

• Negative: No growth of acid-fast bacilli after 6 weeks
• Indicates absence of active mycobacterial infection (but does not rule out latent TB)

Positive Result

• Indicates:
  • Active extrapulmonary tuberculosis
  • Confirmed by identification of *Mycobacterium tuberculosis complex*
  • May require drug susceptibility testing (DST) to guide treatment
• Further testing (e.g., GeneXpert, PCR) often performed for rapid confirmation

Contaminated or Invalid

• May occur due to improper collection or non-sterile containers
• May require repeat sampling

Consequences if Untreated

• Progressive organ damage (e.g., brain, kidneys, spine)
• Tuberculous meningitis leading to stroke, coma, or death
• Skeletal TB causing deformity or paralysis (Pott’s disease)
• Infertility due to genital TB
• Disseminated (miliary) TB spreading throughout the body
• Increased mortality, especially in immunocompromised individuals

Factors Affecting Test Results

• Antibiotic use: prior treatment may suppress growth and cause false-negative results.
• Small sample volume: reduces sensitivity.
• Improper storage or transport: delays or improper temperature can kill bacteria.
• Contamination: with skin flora or other microbes may interfere with culture.
• Low bacterial load: common in extrapulmonary TB, making detection harder.
• Use of preservatives: never add preservatives to culture samples.

FAQs

Limitations

• Long turnaround time: up to 6 weeks due to slow growth of TB bacteria.
• Low sensitivity in paucibacillary samples: few bacteria may not grow in culture.
• Requires proper sample collection — contamination leads to invalid results.
• Cannot distinguish between live and dead bacteria without culture growth.
• Must be interpreted alongside clinical findings, imaging, and other tests (e.g., GeneXpert, ADA levels).

Book Your AFB Culture (Extra Pulmonary): MGIT Test Today

Don’t ignore persistent fever, swollen glands, or neurological symptoms — rule out extrapulmonary TB with accurate testing.

• Accepted Across UAE (Dubai, Abu Dhabi, Sharjah, Ajman, RAK, Umm Al Quwain, Fujairah)
• Fast, Accurate, Confidential Results in 4–6 Weeks
• Price: AED 450
• ✅ CLIA-Certified & CAP-Accredited Labs
• 🔬 Advanced MGIT Technology for Higher Sensitivity
• 🔒 Secure Digital Reporting

ACID FAST BACILLI (AFB) CULTURE (Pulmonary): MGIT Test in Dubai and across the UAE to detect the presence of Mycobacterium tuberculosis — the bacterium that causes tuberculosis (TB). This advanced culture test uses the MGIT (Mycobacteria Growth Indicator Tube) system, a liquid culture method that offers faster and more sensitive detection of TB compared to traditional methods. Ideal for diagnosing pulmonary tuberculosis in patients with symptoms like chronic cough, fever, and weight loss. Results available within 4–6 weeks.

Overview

The AFB Culture (Pulmonary): MGIT Test is a highly sensitive diagnostic tool used to confirm active tuberculosis infection in the lungs. Unlike smear microscopy, which only detects the presence of acid-fast bacilli, the MGIT culture method grows the bacteria in a liquid medium, allowing for definitive identification of Mycobacterium tuberculosis and enabling drug susceptibility testing. The MGIT system automates detection, reducing turnaround time. Results are typically available within 4–6 weeks after sample receipt at the lab.

Why You Need This Test

• Confirm pulmonary tuberculosis (TB) diagnosis when initial AFB smear is positive or inconclusive.
• Diagnose TB in patients with persistent cough (>2–3 weeks), fever, night sweats, or unexplained weight loss.
• Essential for starting appropriate anti-TB treatment and preventing spread.
• Allows for drug susceptibility testing (DST) to detect resistance (e.g., MDR-TB).
• More sensitive than sputum smear microscopy — detects lower bacterial loads.
• Recommended for high-risk individuals: immunocompromised, healthcare workers, or those from TB-endemic regions.
• Available with home sputum collection support across Dubai, Abu Dhabi, Sharjah, and all Emirates.

Symptoms & Risk Factors

Common Symptoms of Pulmonary TB

• Chronic cough lasting more than 2–3 weeks (sometimes with blood)
• Fever and chills, especially in the evening
• Night sweats (soaking bedclothes)
• Unintentional weight loss and loss of appetite
• Chest pain or discomfort when breathing or coughing
• General fatigue or weakness

Risk Factors

• Close contact with someone diagnosed with active TB
• Living or traveling in TB-endemic countries (e.g., South Asia, Africa)
• Immunocompromised status (e.g., HIV, diabetes, long-term steroid use)
• Healthcare workers exposed to TB patients
• Poor living conditions with overcrowding and poor ventilation
• Smoking or lung disease increasing susceptibility

How the Test Works

The MGIT (Mycobacteria Growth Indicator Tube) system is an automated liquid culture method that enhances the growth and detection of Mycobacterium tuberculosis from sputum samples.

• Step 1 — Sample collection: collect 2–3 early morning sputum samples (ideally on consecutive days).
• Step 2 — Processing: sputum is treated to liquefy and concentrate the bacteria.
• Step 3 — Inoculation: sample is placed into MGIT tubes containing growth medium and a fluorescent sensor.
• Step 4 — Incubation: tubes are incubated in an automated system that monitors for bacterial growth.
• Step 5 — Detection: if mycobacteria grow, they consume oxygen, triggering fluorescence — detected by the machine.
• Step 6 — Identification & DST: positive cultures are further tested to confirm M. tuberculosis and check for drug resistance.
• Step 7 — Results: final report delivered securely within 4–6 weeks.

This test is critical for accurate diagnosis and effective treatment planning.

Sample Type

• We take: Expectorated sputum (from deep lungs, not saliva)
• Number of samples: 2–3 early morning specimens (on separate days preferred)
• Volume: at least 3–5 mL per sample
• Collection method: deep cough into sterile container after rinsing mouth
• Transport: samples must be sealed and delivered to the lab promptly (or stored at 4°C if delayed)
• Note: saliva-only or dry cough samples may be rejected due to low diagnostic value

Risks & Safety

• No physical risks — non-invasive sample collection.
• Minimal discomfort during deep coughing.
• Safe for adults and older children who can produce sputum.
• Infection control: patients with suspected TB should wear a mask during collection to prevent transmission.

Result Interpretation

Normal Range

• Negative: No growth of acid-fast bacilli after 6 weeks
• Indicates absence of active pulmonary TB (but clinical correlation needed)

Positive Result

• Indicates:
  • Active pulmonary tuberculosis caused by Mycobacterium tuberculosis
  • Other mycobacterial infections (e.g., NTM – non-tuberculous mycobacteria)
• Further testing (e.g., PCR, DST) will identify the exact species and antibiotic sensitivity.

Contaminated or Invalid

• If other bacteria/fungi overgrow, the sample may be reported as contaminated — repeat collection may be needed.

Consequences if Untreated

• Progressive lung damage leading to cavitation, fibrosis, and respiratory failure.
• Spread to others via airborne droplets (highly contagious).
• Disseminated TB affecting brain (meningitis), bones, kidneys, or spine.
• Increased mortality risk, especially in immunocompromised individuals.
• Development of drug-resistant TB (MDR or XDR) if improperly treated.

Factors Affecting Test Results

• Sample quality: saliva vs. true sputum significantly impacts accuracy.
• Recent antibiotic use: may suppress bacterial growth and cause false-negative results.
• Number of samples: single sample has lower sensitivity; 2–3 improve detection.
• Improper storage: delayed transport or incorrect temperature can reduce viability.
• Smear-negative TB: culture may still be positive even if initial smear is negative.

FAQs

Limitations

• Long turnaround time: 4–6 weeks due to slow growth of TB bacteria.
• Requires high-quality sputum — poor samples lead to false negatives.
• Not suitable for rapid diagnosis; often used alongside GeneXpert MTB/RIF for faster results.
• Positive culture must be confirmed with molecular testing to differentiate TB from NTM.
• Antibiotic use prior to collection may inhibit growth.

Book Your AFB Culture (MGIT) Test Today

Early detection saves lives — get an accurate diagnosis for pulmonary tuberculosis.

• Home Sputum Collection Support (Available in Dubai, Abu Dhabi, Sharjah & All Emirates)
• Advanced MGIT Technology for Higher Sensitivity
• Results in 4–6 Weeks
• Price: AED 400
• ✅ CLIA-Certified Labs | WHO-Recommended Method
• 🫁 Critical for TB Diagnosis & Treatment Planning
• 🔒 Confidential Results | Supports Public Health Reporting

Acid Fast Stain (ZN Stain) for Mycobacterium, AFB Smear Test in Dubai and across the UAE to rapidly detect acid-fast bacilli (AFB), including Mycobacterium tuberculosis — the cause of TB. This essential screening test uses the **Ziehl-Neelsen (ZN) staining technique** to identify bacteria in sputum and other clinical samples. Results available within 1–2 days.

Overview

The Acid Fast Stain (ZN Stain) – AFB Smear Test is a rapid microscopic test used to detect the presence of acid-fast bacilli, primarily Mycobacterium tuberculosis, in clinical specimens such as sputum, bronchoalveolar lavage (BAL), urine, or tissue. The Ziehl-Neelsen (ZN) staining method uses carbol fuchsin and counterstains to highlight mycobacteria under the microscope. These bacteria retain the red dye even after acid-alcohol treatment — hence "acid-fast." This test is a **first-line tool in diagnosing tuberculosis (TB)** and other mycobacterial infections. Results are typically available within 1–2 business days.

Why You Need This Test

• Screen for pulmonary tuberculosis (TB) in patients with persistent cough, fever, or weight loss.
• Diagnose extrapulmonary TB using urine, CSF, lymph node aspirates, or tissue samples.
• Support early detection of active TB infection before culture results are ready.
• Monitor treatment response in known TB patients (declining AFB counts).
• Essential for infection control in hospitals and clinics.
• Fast, cost-effective, and widely used in high-prevalence regions.
• Available with home sputum collection support across Dubai, Abu Dhabi, Sharjah, and all Emirates.

Symptoms & Risk Factors

Common Symptoms

• Chronic cough lasting more than 2–3 weeks
• Coughing up blood (hemoptysis)
• Fever, night sweats, and chills
• Unexplained weight loss and fatigue
• Chest pain or difficulty breathing

Risk Factors

• Close contact with a person diagnosed with active TB
• Living or working in crowded environments (e.g., labor camps, prisons)
• Healthcare workers exposed to TB patients
• Smoking or lung disease (COPD, silicosis)
• Weakened immune system (HIV, diabetes, steroid use)
• Recent travel to or origin from high-TB-burden countries

How the Test Works

The Ziehl-Neelsen (ZN) stain is a histological technique that identifies mycobacteria based on their unique waxy cell wall, which resists decolorization by acid alcohol after staining.

• Step 1 — Sample collection: sputum is collected (preferably early morning, deep cough), or other specimen types (urine, CSF, tissue) are submitted.
• Step 2 — Smear preparation: a thin layer of the sample is spread on a glass slide and heat-fixed.
• Step 3 — Staining: slides are treated with carbol fuchsin (red dye), then decolorized with acid-alcohol, and counterstained with methylene blue.
• Step 4 — Microscopy: examined under oil immersion for red, rod-shaped bacteria (acid-fast bacilli).
• Step 5 — Results: reported as negative or positive with semi-quantitative grading (e.g., 1+ to 4+).

This test provides a rapid clue to TB infection — critical for early isolation and treatment.

Sample Type

• We accept: Sputum (most common), BAL, gastric aspirate, urine, CSF, pleural fluid, tissue biopsies
• Preferred sample: Early morning sputum (3 consecutive days may be requested)
• Volume: 3–5 mL of sputum; minimum 1 mL for other fluids
• Container: Sterile, leak-proof, wide-mouthed sputum cup
• Labeling: Must include patient name, date, and time of collection
• Note: Saliva or oropharyngeal secretions are inadequate — deep cough sputum required

Risks & Safety

• No physical risk from the test itself (non-invasive sample collection).
• Sputum induction (if needed) may cause mild coughing or discomfort.
• Specimen handling follows strict biosafety protocols (BSL-3 for TB suspects).
• Safe for adults and children over 5 years old (younger children may require gastric aspirate).

Result Interpretation

Normal Range

• Negative: No acid-fast bacilli seen (0 AFB per 100 oil immersion fields)
• A negative result does not rule out TB — culture and PCR may still be needed

Positive Results

• Reported as:
  • Scanty: 1–9 AFB in 100 fields
  • 1+: 10–99 AFB in 100 fields
  • 2+: 1–10 AFB per field (in 50 fields)
  • 3+: >10 AFB per field (in 20 fields)
  • 4+: Too numerous to count
• A positive result suggests:
  • Pulmonary tuberculosis
  • Other mycobacterial infections (e.g., M. avium)
  • Requires confirmation with AFB culture and molecular testing (e.g., Xpert MTB/RIF)

Consequences if Untreated

• Progression to severe lung damage and chronic respiratory failure.
• Spread of infection to others via airborne droplets.
• Disseminated (miliary) TB affecting brain, spine, kidneys, or bones.
• TB meningitis — life-threatening if not treated early.
• Drug-resistant TB development with delayed diagnosis.
• Increased mortality, especially in immunocompromised individuals.

Factors Affecting Test Results

• Poor sample quality: saliva instead of deep sputum leads to false negatives.
• Low bacterial load: early or paucibacillary disease may not show AFB.
• Recent antibiotic use: may reduce detectable organisms.
• Improper staining technique: lab-dependent variability (ZN requires skilled technicians).
• Smoker’s pigmentation: can mimic bacilli under microscope (rare).
• Contamination: improper handling may affect accuracy.

FAQs

Limitations

• Low sensitivity: requires 5,000–10,000 bacilli/mL for detection — early TB may be missed.
• Cannot differentiate M. tuberculosis from non-tuberculous mycobacteria (NTM) without further testing.
• Does not detect drug resistance — requires molecular or culture-based methods.
• Highly dependent on sample quality and technician skill.
• Not suitable for monitoring cure — culture is better for treatment follow-up.

Book Your AFB Smear (ZN Stain) Test Today

Suspect TB? Get a rapid answer — early detection saves lives and prevents spread.

• Home Sputum Collection Available (Dubai, Abu Dhabi, Sharjah & All Emirates)
• Fast Results in 1–2 Days
• Price: AED 70
• ✅ CLIA-Certified Labs | WHO-Recommended Method
• 🫁 Trained Staff for Sputum Guidance
• 🔒 Confidential & Secure Reporting

The Anti-Brucella Antibodies test detects the presence of antibodies against Brucella bacteria, which can cause brucellosis. This test measures various health markers that indicate an immune response to the infection. It is essential for diagnosing and monitoring brucellosis.

The Anti-Candida albicans Antibodies (IgM) test measures various health markers related to Candida infections. This test is essential for identifying the presence of IgM antibodies, which indicate an active immune response to Candida albicans, a common yeast infection.

The Anti-Cytomegalovirus (CMV) Antibody, IgG test measures the presence of IgG antibodies against the cytomegalovirus, which can indicate past infection or immunity. This test is essential for assessing various health markers related to CMV exposure.

The Anti-Cytomegalovirus (CMV) Antibody, IgM test measures the presence of IgM antibodies in the blood, indicating a recent infection with the cytomegalovirus. This test is essential for diagnosing active CMV infections and monitoring the immune response.

The Anti-Epstein-Barr Virus (EBV) Antibody test measures the presence of IgG antibodies in the blood, indicating past exposure to the Epstein-Barr virus. This test helps in assessing various health markers related to viral infections and immune response.

The Anti-Epstein-Barr Virus (EBV) Antibody, IgM test measures the presence of IgM antibodies in response to an EBV infection. This test is crucial for diagnosing recent infections and monitoring various health markers associated with EBV.

The Anti-Haemophilus influenzae B antibodies test measures the presence of antibodies against the Haemophilus influenzae type B bacteria. This test is essential for assessing immunity and can help identify individuals at risk for infections caused by this pathogen.

The Anti-Helicobacter pylori Antibodies test screens for the presence of antibodies against Helicobacter pylori, a bacterium linked to various gastrointestinal conditions. This test measures various health markers that can indicate infection or inflammation in the stomach.

The Anti-Influenza A and B Antibodies test measures the presence of antibodies that indicate an immune response to influenza A and B viruses. This test is essential for diagnosing influenza infections and monitoring recovery. It provides valuable information regarding various health markers related to respiratory infections.

The Anti-Mumps Antibodies, IgG test measures the presence of IgG antibodies against the mumps virus, indicating past infection or vaccination status. This test is essential for assessing immunity and can help in understanding the body's response to the mumps virus.

The Anti-Mumps Antibodies, IgM test detects the presence of IgM antibodies against the mumps virus, indicating a recent infection. This test is crucial for diagnosing mumps and monitoring various health markers related to viral infections.

The Anti-Parvovirus B19 Antibodies (IgG) test detects the presence of IgG antibodies in the blood, indicating past exposure to the Parvovirus B19. This test measures various health markers related to the immune response against this virus, which can be significant in diagnosing certain conditions.

The Anti-Parvovirus B19 Antibodies (IgM) test detects the presence of IgM antibodies in the blood, indicating a recent infection with Parvovirus B19. This test helps measure various health markers related to the immune response against the virus.

Detects immunity to rubella (German measles).

The Anti-Toxoplasma Antibodies, IgG test measures the presence of IgG antibodies in the blood, which indicate a past infection with Toxoplasma gondii. This test is essential for assessing immune response and can help in monitoring certain health conditions related to this parasite.

The Anti-Toxoplasma Antibodies, IgM test measures the presence of IgM antibodies in the blood, which indicate a recent infection with the Toxoplasma gondii parasite. This test is crucial for diagnosing acute toxoplasmosis and monitoring the immune response to the infection.

The Anti-Varicella Zoster Antibodies, IgG test measures the presence of antibodies against the varicella zoster virus, which causes chickenpox and shingles. This test is essential for assessing immunity to the virus and can help in various clinical situations.

The Anti-Varicella Zoster Antibodies, IgM test measures the presence of IgM antibodies in the blood, which indicate a recent infection with the varicella zoster virus. This test is crucial for diagnosing conditions related to chickenpox and shingles.

The Aspergillus (Galactomannan) Antigen test detects the presence of galactomannan, a polysaccharide released by Aspergillus species. This test measures various health markers associated with fungal infections, particularly in immunocompromised patients.

The Babesia microti Antibodies IgG and IgM test detects antibodies against the Babesia microti parasite, which can cause a malaria-like illness. This test measures various health markers to help assess exposure to this parasite and the body's immune response.

The Bartonella Antibody Profile is a diagnostic test that measures specific antibodies to Bartonella henselae and Bartonella quintana. It evaluates IgG and IgM antibodies, which can indicate current or past infections, aiding in the diagnosis of related conditions.

The Brucella agglutination test is a serological test used to detect antibodies against Brucella species in the serum or plasma. This test measures various health markers that indicate the presence of brucellosis, an infectious disease caused by bacteria from the Brucella genus.

The Brucella antibody IgG test is used to detect the presence of IgG antibodies against Brucella species in the blood. This test measures various health markers that indicate exposure to the bacteria, which can lead to brucellosis, a serious infectious disease.

The Brucella antibody IgM test is designed to detect the presence of IgM antibodies against Brucella species in the blood. This test measures various health markers that can indicate an active brucellosis infection, which is important for timely diagnosis and treatment.

The Brucella Total Antibodies test detects the presence of antibodies against Brucella bacteria, which can cause brucellosis. This test measures the immune response to the infection, helping in the diagnosis of this zoonotic disease.

The Candida Albicans Detection test utilizes Real-Time PCR to identify the presence of Candida Albicans in urine or swab specimens. This test measures various health markers associated with fungal infections, providing crucial information for diagnosis and treatment.

The Candida Albicans Total Antibodies Serum test measures various health markers related to the immune response against Candida Albicans, a common yeast that can cause infections. This test is essential for diagnosing and monitoring conditions associated with Candida overgrowth.

The Candida dubliniensis PCR test is a molecular diagnostic tool that detects the presence of Candida dubliniensis in urine or swab samples. This test measures various health markers related to fungal infections, providing timely and accurate results for effective treatment.

The Candida glabrata PCR test is a molecular diagnostic tool used to detect the presence of Candida glabrata in urine or swab specimens. This test measures various health markers to help identify infections caused by this yeast, which can be particularly important for immunocompromised individuals.

The Candida krusei PCR test is a molecular diagnostic tool that detects the presence of Candida krusei in urine or swab samples. This test measures various health markers related to fungal infections, providing critical information for diagnosis and treatment.

The Candida lusitaniae PCR test detects the presence of Candida lusitaniae in urine or swab samples. This test measures various health markers to help identify infections caused by this specific fungus, which can be critical in immunocompromised patients.

The Candida parapsilosis PCR test detects the presence of Candida parapsilosis in urine or swab samples. This test measures various health markers to help diagnose and monitor fungal infections. It is performed using Real-Time PCR technology for accurate results.

The Candida tropicalis PCR test is a molecular diagnostic tool that detects the presence of Candida tropicalis in urine or swab specimens. This test measures various health markers to help identify fungal infections and their potential impact on health.

This test measures the presence of IgG and IgM antibodies to Coccidioides immitis, a fungus that can cause coccidioidomycosis. It is essential for diagnosing and monitoring infections related to this pathogen.

The Cryptococcus Antigen test measures specific health markers related to fungal infections, particularly cryptococcosis. This test is crucial for diagnosing and monitoring the presence of Cryptococcus neoformans in the bloodstream.

The Cryptococcus neoformans Antigen test detects the presence of antigens produced by the Cryptococcus neoformans fungus. This test measures various health markers that can indicate fungal infections, particularly in immunocompromised patients. Early detection is crucial for effective treatment and management.

The Cytomegalovirus (CMV) IgG Avidity test measures the avidity of IgG antibodies to CMV, helping to determine the timing of infection. This test is essential for assessing recent infections and can aid in the management of patients with suspected CMV-related complications.

The Cytomegalovirus (CMV) IgM test detects the presence of IgM antibodies in the serum, indicating a recent infection. This test measures various health markers related to CMV, which can affect individuals with weakened immune systems. Early detection is crucial for effective management.

The Dengue antibody IgG test is essential for detecting the presence of IgG antibodies in the blood, indicating a past infection with the dengue virus. This test measures various health markers that help in understanding the immune response to dengue. It is crucial for diagnosing and monitoring dengue fever.

The Dengue Antibody, IgM (Qualitative) test detects the presence of IgM antibodies in the serum, indicating a recent dengue virus infection. This test measures various health markers to help assess the immune response to the virus, providing crucial information for diagnosis.

The Dengue IgM antibody test is designed to detect the presence of IgM antibodies in the blood, indicating a recent dengue virus infection. This test measures various health markers that help in diagnosing and monitoring dengue fever.

The Dengue NS1 antigen detection test is a crucial diagnostic tool for identifying dengue virus infections. This test measures various health markers related to the presence of the dengue virus in the body, allowing for timely diagnosis and management.

EBV IgG Panel Test – Epstein-Barr Virus Antibody Detection The EBV IgG Panel is a specialized diagnostic test designed to detect IgG antibodies against the Epstein-Barr Virus (EBV). This test plays a crucial role in identifying past or current EBV infections, which are associated with a range of health conditions, including infectious mononucleosis and potential long-term complications. By measuring IgG antibodies, this test provides valuable insights into your immune system's response to EBV, helping healthcare providers diagnose, monitor, and manage related conditions effectively. Why You Need This Test The EBV IgG Panel is essential for individuals experiencing symptoms or health concerns that may be linked to Epstein-Barr Virus. EBV is a common virus that infects most people at some point in their lives, often without noticeable symptoms. However, in some cases, it can lead to infectious mononucleosis or contribute to chronic fatigue syndrome, autoimmune disorders, or even certain cancers. This test helps determine whether your body has been exposed to EBV and whether your immune system has developed antibodies to fight it. Early detection and monitoring of EBV-related conditions can prevent complications and guide appropriate treatment plans. Symptoms That Indicate This Test You may need the EBV IgG Panel if you are experiencing any of the following symptoms or conditions: - Persistent fatigue or weakness - Fever, sore throat, or swollen lymph nodes - Enlarged spleen or liver - Unexplained muscle aches or joint pain - Chronic fatigue syndrome symptoms - Suspected infectious mononucleosis - Recurrent or prolonged flu-like symptoms - Autoimmune-related health concerns

The Epstein Barr Virus Antibody IgG test measures the presence of IgG antibodies in the blood, indicating past infection with the Epstein Barr virus. This test helps assess immune response and can provide insights into various health markers related to viral infections.

The Epstein Barr Virus Antibody IgM test detects the presence of IgM antibodies in response to an Epstein Barr virus infection. This test measures various health markers that can indicate recent infection or reactivation of the virus, which is commonly associated with infectious mononucleosis.

The Epstein-Barr Virus VCA IgG Panel is a blood test that measures various health markers related to the Epstein-Barr virus, which can indicate past infections. This test is essential for understanding immune response and can help in diagnosing conditions associated with the virus.

The Epstein-Barr Virus VCA IgM Panel is a crucial test that measures various health markers related to the Epstein-Barr virus, which is known to cause infectious mononucleosis. This test helps in the early detection of recent infections and can guide appropriate clinical management.

The Fluid LDH (Lactate Dehydrogenase) test measures the levels of LDH enzyme in body fluids, such as pleural or peritoneal fluid. This test is essential for diagnosing various medical conditions, including infections, tissue damage, and certain cancers, providing valuable insights into the underlying health issues.

Detects H. pylori protein in stool.

The Hepatitis A Virus (HAV) Antibodies, IgG test detects the presence of IgG antibodies in the serum, indicating past infection or immunity to Hepatitis A. This test measures various health markers related to liver function and immune response.

The Hepatitis A Virus (HAV) Antibodies test measures the presence of antibodies in the serum, indicating past exposure to the virus. This qualitative test helps assess immunity and can be crucial for understanding your liver health.

The Hepatitis A Virus (HAV) RNA Detection test uses PCR technology to identify the presence of the virus in the bloodstream. This test measures various health markers related to Hepatitis A infection, aiding in the diagnosis and monitoring of the disease.

The Hepatitis A Virus (HAV), IgG test measures the presence of antibodies in the blood that indicate past infection with the Hepatitis A virus. This test is essential for understanding immunity status and assessing potential exposure to the virus.

The Hepatitis A Virus (HAV), IgM test detects the presence of IgM antibodies in the blood, indicating a recent infection with the Hepatitis A virus. This test measures various health markers related to liver function and viral infection status.

Hepatitis B “s” Ag (HBs Ag) Test – Screen for Hepatitis B Infection

 

The Hepatitis B Surface Antigen (HBs Ag) Test detects the presence of the hepatitis B surface antigen in the blood, indicating an active hepatitis B virus (HBV) infection. This test is a cornerstone of viral hepatitis screening and is used to diagnose acute or chronic HBV, monitor infection status, and determine immunity or carrier state.

 

Symptoms That Indicate You May Need This Test

 

If you experience any of the following, especially with risk factors like IV drug use, unprotected sex, or travel to endemic areas:

 

 
• Fatigue and weakness
 
• Jaundice (yellowing of skin and eyes)
 
• Dark urine and pale stools
 
• Abdominal pain, especially in the upper right quadrant
 
• Nausea, vomiting, or loss of appetite
 
• Joint pain and fever
 

 

These may indicate acute hepatitis B infection. However, many people are asymptomatic, making screening essential.

 

Natural Production and Role in the Body

 

The hepatitis B surface antigen (HBsAg) is a protein found on the surface of the hepatitis B virus. It appears in the blood 6–16 weeks after exposure and is the first marker of infection. Its presence indicates that the virus is actively replicating and the person is contagious. In acute infection, HBsAg usually disappears within 6 months. Persistence beyond 6 months suggests chronic infection.

 

What Happens If Left Untreated?

 

Chronic hepatitis B can lead to severe liver complications, including:

 

 
• Cirrhosis (scarring of the liver)
 
• Liver failure
 
• Hepatocellular carcinoma (liver cancer)
 
• Transmission to others through blood or bodily fluids
 
• Fulminant hepatitis (rare but life-threatening)
 

 

Early detection allows for monitoring, antiviral treatment, and lifestyle changes to protect liver health.

 

Test Overview

 

A 2 mL blood sample is collected in an SST or red-top tube. The test uses immunoassay methods to detect HBsAg in serum. Results are typically available the same day. A positive result requires follow-up testing (e.g., HBV DNA, liver function tests) to determine infection stage and treatment needs.

 

Frequently Asked Questions (FAQs)

 

Can I have hepatitis B without symptoms?

 

Yes—many people, especially children, have no symptoms but can still spread the virus.

 

Does a positive test mean I’m immune?

 

No—positive HBsAg means active infection. Immunity is indicated by positive anti-HBs antibodies, usually from vaccination or recovery.

 

Who should get tested?

 

Recommended for pregnant women, healthcare workers, people with multiple sexual partners, IV drug users, and those from regions with high HBV prevalence.

The Hepatitis B Core Antibodies (HBc Total) test measures the presence of antibodies that indicate a past or ongoing infection with the hepatitis B virus. This test is crucial for assessing liver health and determining the immune response to the virus.

The Hepatitis B Core Antibody IgM (HBc IgM) test measures the presence of IgM antibodies against the core antigen of the Hepatitis B virus. This test is crucial for diagnosing acute Hepatitis B infections and helps in assessing the immune response to the virus.

The Hepatitis B e Antibody (Anti-HBe) test measures various health markers related to the Hepatitis B virus. This test is crucial for assessing the immune response to the virus and determining the stage of infection.

The Hepatitis B e Antigen (HBe Ag) test is essential for detecting the presence of the hepatitis B virus in the bloodstream. This test measures various health markers that indicate the level of viral replication and the potential for liver damage.

The Hepatitis B Surface Antibody (Anti-HBs) test measures the presence of antibodies that indicate immunity to the Hepatitis B virus. This test is essential for assessing recovery from Hepatitis B infection or the effectiveness of vaccination.

Detects antibodies to Hepatitis C virus.

The Hepatitis E Virus (HEV) Antibody, IgM test detects the presence of IgM antibodies against the Hepatitis E virus in the blood. This test helps measure various health markers related to Hepatitis E infection, providing crucial information for diagnosis and monitoring.

The Hepatitis E Virus (HEV) Antibody test measures the presence of IgG antibodies in the blood, indicating past exposure to the virus. This test helps assess immune response and can provide insights into various health markers related to hepatitis E infection.

The Hepatitis E Virus (HEV) Antibody test measures the presence of antibodies in the blood that indicate a recent or past infection with the virus. This test helps in assessing the immune response to HEV and can provide insights into various health markers related to liver function.

The Hepatitis Marker Screen (HAV IgM) is a crucial test that detects the presence of antibodies indicating recent infection with Hepatitis A virus. This test measures various health markers to assess liver function and potential viral infections, providing essential information for diagnosis and treatment.

Herpes Simplex Virus (HSV)-I, IgM Test in UAE

Overview

The HSV-1 IgM blood test helps detect recent or active infection caused by Herpes Simplex Virus type 1 (HSV-1). HSV-1 is most commonly associated with oral herpes (cold sores) and can also cause genital herpes, eye infections, and complications in pregnancy. Testing requires a simple blood sample, and results are typically ready within 2 days.

Symptoms & Risk Factors

Common Symptoms

• Painful blisters or cold sores on lips, mouth, or face
• Burning, itching, or tingling sensation before sores appear
• Swollen lymph nodes and mild fever
• Sore throat or flu-like illness
• Genital ulcers or painful urination (if sexually transmitted)

Risk Factors

• Unprotected oral or sexual contact with an infected person
• Weakened immune system (HIV, cancer therapy, chronic illness)
• Pregnancy — increased risk of neonatal herpes transmission
• Sharing utensils, razors, or close contact during outbreaks

How the Test Works

1. Sample collection: A small blood sample (serum) is drawn from the arm.
2. Laboratory analysis: The sample is tested for HSV-1 IgM antibodies, which appear in early or reactivated infection.
3. Results: A secure report is provided within 2 working days.

Specimen (Sample Type)

• Sample required: Serum, plain
• Volume: 1 mL
• Collection method: Standard venipuncture

Risks & Safety

• Mild pain, swelling, or bruising at the blood draw site
• Occasional dizziness or fainting
• Minimal infection risk with sterile technique

About Herpes Simplex Virus (HSV-1)

HSV-1 is a lifelong viral infection that becomes dormant in nerve cells and may reactivate under certain conditions. While it most often causes cold sores, it can also lead to genital herpes, eye infections, or rarely encephalitis. Detecting HSV-1 IgM antibodies helps confirm recent or active infection for timely care.

Result Interpretation

• Positive IgM: Indicates recent or current HSV-1 infection.
• Negative IgM: Suggests no recent infection; past exposure may still be present (check HSV-1 IgG).
• Your clinician may recommend HSV IgG, PCR, or culture for confirmation.

Consequences if Untreated

• Recurrent painful outbreaks that affect daily comfort
• Higher risk of transmission to partners or newborns
• Rare but serious complications (e.g., herpes encephalitis, eye damage)
• Emotional distress and social stigma during visible outbreaks

Factors Affecting Symptoms

• Stress, illness, or weakened immunity can trigger recurrences
• Sunlight exposure or fever may reactivate the virus
• Overall health and nutrition influence recurrence frequency

Related Tests

• HSV-1 IgG Test (to detect past infection)
• HSV-2 IgM/IgG Tests
• PCR for HSV (detects viral DNA directly)
• HIV & Syphilis Panel (rule out co-infections)

HIV Combi Test – Early Detection of HIV-1 and HIV-2 Infection

The HIV Combi Test detects both HIV-1 and HIV-2 antibodies and the p24 antigen in blood, making it one of the most accurate and early diagnostic tools for HIV infection. This fourth-generation test can identify HIV as early as 2–3 weeks after exposure, significantly reducing the window period and enabling prompt medical intervention.

Symptoms That Indicate You May Need This Test

If you've had potential exposure to HIV (e.g., unprotected sex, shared needles) and experience any of the following flu-like symptoms, testing is crucial:

• Fever, chills, or night sweats
• Fatigue and body aches
• Sore throat and swollen lymph nodes
• Rash on the trunk or limbs
• Mouth ulcers or genital sores

These may indicate acute HIV infection (seroconversion illness), which often goes unrecognized.

Natural Production and Role in the Body

After HIV enters the body, the virus begins replicating rapidly. The p24 antigen is a viral protein that appears in the blood 10–15 days post-exposure, before antibodies develop. Antibodies to HIV-1 and HIV-2 typically appear 3–8 weeks later. The combi test detects both markers, allowing earlier diagnosis than antibody-only tests.

What Happens If Left Untreated?

Untreated HIV progressively destroys CD4 immune cells, leading to:

• Severe immunodeficiency (AIDS)
• Opportunistic infections (e.g., TB, pneumocystis pneumonia)
• Certain cancers (e.g., Kaposi’s sarcoma)
• Neurological complications
• Transmission to others through blood, sexual contact, or mother-to-child

Early detection allows immediate antiretroviral therapy (ART), which suppresses the virus and prevents progression.

Test Overview

A 2 mL blood sample is collected in an SST or red-top tube. The test uses chemiluminescent immunoassay (CLIA) technology to detect p24 antigen and HIV-1/2 antibodies simultaneously. Results are typically available the same day. A positive result requires confirmation with a Western Blot or HIV-1 RNA PCR test.

Frequently Asked Questions (FAQs)

How soon can this test detect HIV?

As early as 2–3 weeks after exposure, thanks to p27 antigen detection.

Is this test more accurate than older HIV tests?

Yes—fourth-generation combi tests reduce the diagnostic window by 5–7 days compared to antibody-only tests.

Can I test negative and still be infected?

Possible during the window period. Retesting after 4 weeks is recommended if exposure was recent.

The Influenza A & B - Manual test is designed to detect the presence of influenza viruses A and B in the body. This test measures various health markers to help identify an influenza infection, which can be crucial for timely treatment and management.

The Influenza Virus A IgG test detects antibodies against the Influenza A virus, providing insight into your immune response to past infections. This test measures various health markers that indicate exposure to the virus and helps assess immunity levels. It is essential for understanding your body's defense against influenza.

The Influenza Virus A IgM test detects the presence of IgM antibodies in response to the influenza A virus. This test helps in identifying recent infections and monitoring various health markers associated with the virus.

The Influenza Virus B IgG test measures the presence of IgG antibodies in the blood, indicating past exposure to the influenza B virus. This test helps in assessing the immune response to the virus and can be useful in understanding the patient's health status regarding influenza infections.

The Influenza Virus Type A Antigen test detects the presence of the influenza A virus in the body. It measures various health markers to help identify an active infection, providing crucial information for diagnosis and treatment.

The Influenza Virus Type B Antigen test detects the presence of the influenza type B virus in the body. This test measures various health markers to help identify an active infection. It is essential for timely diagnosis and treatment of influenza.

The LDH (Lactate Dehydrogenase) test on ascitic fluid measures the levels of lactate dehydrogenase enzyme in fluid collected from the abdominal cavity. This test helps in diagnosing conditions such as infections, liver disease, or malignancies by assessing the nature of the fluid and its potential underlying causes.

The LDH (Lactate Dehydrogenase) test on cerebrospinal fluid (CSF) measures the levels of lactate dehydrogenase enzyme in the CSF. This test is crucial for diagnosing various neurological conditions, including infections, inflammation, and certain types of cancer affecting the central nervous system.

The LDH (Lactate Dehydrogenase) test on pleural fluid measures the levels of lactate dehydrogenase enzyme in the fluid surrounding the lungs. This test helps in diagnosing various conditions, including infections, malignancies, and inflammatory diseases affecting the pleura.

The LDH (Lactate Dehydrogenase) test on synovial fluid measures the level of lactate dehydrogenase enzyme in the joint fluid. This test is crucial for diagnosing conditions such as joint inflammation, infections, and other disorders affecting the synovial membrane.

The Lyme Disease (Borrelia Burgdorferi) IgG test detects antibodies produced in response to the Borrelia burgdorferi bacteria, which causes Lyme disease. This test measures various health markers to help assess exposure to the infection and guide further clinical decisions.

The Lyme Disease (Borrelia Burgdorferi) IgM test detects antibodies produced in response to the Borrelia burgdorferi bacteria, which causes Lyme disease. This test measures various health markers to help diagnose an active infection.

Microscopic examination of blood for malaria parasites.

The Measles IgG test measures the presence of IgG antibodies to the measles virus in the blood, indicating immunity or past infection. This test is essential for assessing immunity status, especially in individuals who may be at risk of measles exposure.

The Measles IgM test detects the presence of IgM antibodies in the blood, indicating a recent infection with the measles virus. This test measures various health markers related to the immune response against measles.

The Mumps Antibody IgG test measures the presence of IgG antibodies against the mumps virus, indicating past infection or vaccination status. This test is essential for assessing immunity and can help in diagnosing mumps-related complications.

The Mumps Antibody IgM test detects the presence of IgM antibodies in the blood, indicating a recent infection with the mumps virus. This test measures various health markers related to the immune response to the virus, helping healthcare providers assess the patient's condition effectively.

The Mycobacterium tuberculosis (TB) PCR test detects the presence of tuberculosis bacteria in various specimens such as fluid, sputum, or urine. This test measures various health markers to help diagnose active TB infections and monitor treatment effectiveness.

The Mycoplasma IgM test detects the presence of IgM antibodies against Mycoplasma, which can indicate an active infection. This test measures various health markers related to Mycoplasma infections, helping healthcare providers assess the patient's condition effectively.

The Mycoplasma Pneumoniae antibody IgG test measures the presence of antibodies against Mycoplasma pneumoniae, a common cause of respiratory infections. This test helps in assessing the immune response to the infection and can indicate past exposure or ongoing infection.

The Mycoplasma Pneumoniae antibody IgM test detects the presence of IgM antibodies in the serum, indicating an active infection. This test measures various health markers related to respiratory infections and helps in diagnosing pneumonia caused by Mycoplasma pneumoniae.

The Mycoplasma Pneumoniae IgG test detects antibodies in the serum that indicate a past infection with Mycoplasma pneumoniae, a common cause of respiratory illnesses. This test measures various health markers related to the immune response against this pathogen, helping to assess previous exposure.

The Mycoplasma Pneumoniae IgM test is a qualitative serum test that detects the presence of IgM antibodies against Mycoplasma pneumoniae, a common cause of respiratory infections. This test measures various health markers to help diagnose infections and monitor immune response.

Blood smear to detect Leishmania parasites.

Indicates recent or active rubella infection.

Salmonella Antibodies Test – Detect Typhoid and Systemic Infections

 

The Salmonella Antibodies Test detects IgG and IgM antibodies against Salmonella typhi and other Salmonella species in the blood. This serological test is used to diagnose typhoid fever and systemic salmonellosis, particularly when stool cultures are negative or delayed. It is especially valuable for travelers returning from endemic regions.

 

Symptoms That Indicate You May Need This Test

 

If you have the following symptoms, especially after consuming contaminated food or traveling abroad:

 

 
• High, sustained fever (103–104°F)
 
• Abdominal pain and bloating
 
• Diarrhea or constipation
 
• Headache, weakness, and fatigue
 
• Loss of appetite
 
• Rose spots (pink, flat spots on the chest or abdomen)
 

 

These are classic signs of typhoid fever caused by S. typhi.

 

Natural Production and Role in the Body

 

When Salmonella bacteria enter the body through contaminated food or water, the immune system responds by producing specific antibodies. IgM appears within 1 week of infection, indicating acute or recent exposure. IgG rises later and may persist for months or years, suggesting past infection or vaccination.

 

What Happens If Left Untreated?

 

Untreated typhoid fever can lead to severe complications, including:

 

 
• Intestinal perforation and peritonitis
 
• Life-threatening sepsis
 
• Encephalopathy or meningitis
 
• Chronic carrier state (asymptomatic shedding in stool)
 
• Death in up to 10–20% of untreated cases
 

 

Early diagnosis and antibiotic treatment are critical to recovery.

 

Test Overview

 

A 2 mL blood sample is drawn from a vein and collected in an SST or red-top tube. The test detects antibody titers in serum. A rising titer between acute and convalescent samples (taken 1–2 weeks apart) confirms active infection. Results are typically available the same day.

 

Frequently Asked Questions (FAQs)

 

Can this test give false positives?

 

Yes—previous infection, vaccination, or cross-reacting infections (like malaria) may cause elevated IgG. IgM is more specific for recent infection.

 

Is this test better than stool culture?

 

It's complementary. Blood antibodies are useful when cultures are negative or delayed.

 

Do I need a repeat test?

 

Sometimes—doctors may order a second test 1–2 weeks later to confirm rising antibody levels.

The Toxoplasma Antibodies, IgM test measures the presence of IgM antibodies in the blood, which can indicate a recent infection with Toxoplasma gondii. This test is essential for assessing potential risks, especially in pregnant women or immunocompromised individuals.

The Toxoplasma Avidity test measures the immune response to Toxoplasma gondii, a parasite that can cause serious health issues. This test evaluates various health markers to determine if a recent infection has occurred, aiding in the diagnosis of toxoplasmosis.

The Varicella Zoster antibody IgG test measures the presence of antibodies in the serum that indicate immunity to the Varicella Zoster virus. This test is essential for assessing past infection or vaccination status, helping to determine an individual's risk for developing shingles or chickenpox.

The Varicella Zoster antibody IgM test detects the presence of IgM antibodies, indicating a recent infection with the varicella zoster virus. This test measures various health markers related to the immune response against the virus, helping to diagnose conditions such as chickenpox and shingles.

The Widal Test is a serological test used to diagnose typhoid fever and paratyphoid fever by detecting specific antibodies in the blood. This test measures the presence of antibodies against Salmonella typhi and Salmonella paratyphi, helping healthcare providers confirm infections caused by these bacteria.

The Widal Test is a serological test used to detect the presence of specific antibodies against Salmonella bacteria, which can indicate typhoid fever and other related infections. It measures various health markers that help in diagnosing these conditions. This test is essential for identifying infections and guiding appropriate treatment.